United States· US:0469-0420_7e6e45d4-9266-4451-b6b6-0d054bbcab63
CRESEMBA
A medicinal product containing isavuconazonium sulfate, registered in United States by Astellas Pharma US, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ISAVUCONAZONIUM SULFATE
- Manufacturer
- Astellas Pharma US, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1104690420011 VIAL, SINGLE-DOSE in 1 CARTON (0469-0420-01) / 5 mL in 1 VIAL, SINGLE-DOSE
- ndc110469-0420-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Isavuconazonium sulfate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCresembaBasilea Pharmaceutica Deutschland GmbH
- SwitzerlandCresemba
- CzechiaCRESEMBABasilea Pharmaceutica Deutschland GmbH, Lörrach
- BelgiumCresemba 100 mgBasilea Pharmaceutica Deutschland
- Japanイサブコナゾニウム硫酸塩旭化成セラピューティクス
- NorwayCresembaBasilea Pharmaceutica Deutschland GmbH
- SwedenCRESEMBA 100 mg Kapsel, hårdBasilea Pharmaceutica Deutschland GmbH
- IrelandCRESEMBA 100 mg hard capsulesBasilea Pharmaceutica Deutschland GmbH
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Cresemba
- Norway · Cresemba
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a870854d-20ab-4419-bfdf-90105600abee GET /v1/drugs/a870854d-20ab-4419-bfdf-90105600abee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "40",
"substance": "ISAVUCONAZONIUM SULFATE",
"productndc": "0469-0420",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA207501",
"marketing_category": "NDA"
}See everything about isavuconazonium sulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.